TABLE 4.
LD50 (μg/g) | Challenge dose | PCAV (16.2 ± 1.1 mg/ml) | |||||
ED50 (μl) | ER50 (mg/ml) | P (mg/ml) | Normalized P (mg/g) | ||||
Alpha-neurotoxins | NS-SαNTX | 0.18 (0.12–0.29) | 5 LD50 | 91.24 (58.29–142.80) | 0.25 (0.16–0.40) | 0.20 | 12.18 |
NP-SαNTX | 0.10 (0.06–0.15) | 5 LD50 | 44.94 (29.60–68.23) | 0.28 (0.17–0.42) | 0.22 | 13.74 | |
Venom | Naja samarensis* | 0.20 (0.16–0.25) | 5 LD50 | 120.86 (104.79–139.40) | 0.21 (0.17–0.26) | 0.17 | 10.21 |
Naja philippinensis # | 0.18 (0.12–0.27) | 5 LD50 | 44.94 (29.60–68.23) | 0.50 (0.33–0.75) | 0.40 | 24.72 |
LD50 (Lethal dose): Venom dose (µg/g) at which 50% of the mice were dead.
ED50 (Median effective dose): Antivenom dose (μl) at which 50% of tested mice survived.
ER50 (Median effective ratio): Antivenom dose (mg/ml) corresponding to ED50.
P: Potency of antivenom (mg venom neutralized per ml antivenom).
Normalized P: Potency of antivenom (mg venom neutralized per g antivenom).
Abbreviations: NP-SαNTX, Naja philippinensis short-chain alpha-neurotoxin; NS-SαNTX, Naja samarensis short-chain alpha-neurotoxin; PCAV, Philippine Cobra Antivenom.